Investigational Preventative HIV Vaccine Well-Tolerated, Elicited Antibody Responses in Early Clinical Trials

Beth Israel Deaconess Medical Center Press Release

Mosaic-based vaccine includes characteristics from several common strains of HIV.

In the APPROACH multi-site, randomized and controlled study of 393 healthy people in five countries, investigational vaccines were well-tolerated and elicited antibody responses in 100 percent of volunteers.

Read More